The neurological sequelae of chronic Mn exposure include psychiatric, cognitive and motor deficits, suggesting the potential involvement of multiple neurotransmitter systems and brain regions. Available evidence in rodents suggests that Mn causes dysregulation of glutamatergic and GABAergic neurotransmitter systems. However, this has never been studied comprehensively in the non-human primate brain. Cynomolgus macaques were given weekly i.v. injections of 3.3-5.0mg Mn/kg, 5.0-6.7mg Mn/kg, or 8.3-10.0mg
Introduction
Manganese (Mn) is a naturally occurring element that is an essential nutrient, and cofactor for certain metalloenzymes required for normal cellular homeostasis (Aschner and Aschner 2005) . While Mn consumption is necessary in humans, excessive exposure is associated with adverse psychiatric, cognitive, and motor effects. Increased human exposures to Mn occur in a variety of settings. For example, excessive Mn exposure occurs in occupations such as ferroalloy smelting (Mergler et al. 1994) , welding (Bowler et al. 2003) , mining (Montes et al. 2008; Rodriguez-Agudelo et al. 2006) , battery assembly (Bader et al. 1999) , and the manufacture of glass and ceramics (Srivastava et al. 1991) .
Iatrogenic exposure to manganese may occur to individuals receiving total parenteral nutrition (Hardy et al. 2008; Iinuma et al. 2003) . Medical conditions such as liver failure have also been shown to accumulate Mn in the brain (Brunberg et al. 1991) .
Furthermore, the use of methylcyclopentadienyl manganese tricarbonyl (MMT) as a gasoline anti-knock agent has raised concerns over potential increased environmental Mn exposures to the general population (Gulson et al. 2006) .
The neurological sequelae of exposure to high levels of Mn occur in stages. The early phase of Mn intoxication involves a psychiatric component, characterized in part by irritability, apathy, and psychosis, and is sometimes called Mn mania (Mergler and Baldwin 1997) . Deficits in measures of executive function, such as short-term memory and computational ability, are also early manifestations of Mn neurotoxicity (Lucchini et al. 1995) . Characteristics of the late phase of Mn intoxication include dystonia, rigidity and gait abnormalities (Lucchini et al. 1999) .
Magnetic resonance imaging (MRI) studies are in agreement that Mn accumulates to a large extent in the globus pallidus (Hauser et al. 1996; Josephs et al. 2005) . The globus pallidus and related basal ganglia structures have therefore been a focus of the preponderance of the research efforts on Mn neurotoxicity. Several nonhuman primate studies show that Mn accumulates in other brain areas but not to the same extent as the globus pallidus (Bock et al. 2008; Dorman et al. 2006; Guilarte et al. 2006b ). Examination of other brain regions may elucidate possible mechanisms by which Mn produces its early effects.
There is a persistent notion in the literature that a component of Mn neurotoxicity may be mediated by dysregulation of excitatory glutamatergic and inhibitory γ-aminobutyric acid (GABA) neurotransmission. Early evidence for this hypothesis stems from studies conducted two decades ago in which it was shown that chronic Mn administration to rodents produced an increase in striatal GABA concentrations (Gianutsos and Murray 1982) and altered the levels of glutamic acid decarboxylase (Lai et al. 1981) , the enzyme that converts glutamate to GABA. Since then, a series of rodent studies from several laboratories suggested that Mn exposure increases brain glutamate and GABA concentrations (Gwiazda et al. 2002; Lipe et al. 1999; Reaney et al. 2006 ) while other studies suggest opposite effects (Brouillet et al. 1993; Seth et al. 1981; Zwingmann et al. 2007) . Other research suggests that chronic Mn 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by guest on November 4, 2016 http://toxsci.oxfordjournals.org/ Downloaded from exposure in rodents has no effect on amino acid neurotransmitter concentrations in the corpus striatum (Bonilla et al. 1994) .
There is much more limited data available on the effect of chronic Mn exposure in non-human primates and its effects on the glutamatergic and GABAergic systems. For example, it was shown that over two years of repeated monthly injections of Mn does not alter GABAa receptor density (Eriksson et al. 1992) . Other studies showed that non-human primates exposed to Mn via inhalation for 13 weeks did not have altered total glutamate or GABA tissue levels in the globus pallidus, caudate and putamen (Struve et al. 2007 ).
However, in several brain regions of the same animals, they noted increased mRNA expression and decreased protein levels of GLAST and GLT-1-the two main astrocytic glutamate transporters-and glutamine synthetase (GS), the enzyme that converts glutamate to glutamine, (Erikson et al. 2007) .
Given the contradictory data available from rodent studies, and the paucity of experiments conducted in non-human primates, a comprehensive study is warranted on the effect of chronic Mn exposure on the glutamatergic and GABAergic neurotransmitter systems and their receptors and transporters throughout the brain. Therefore, we used a model of chronic Mn exposure in non-human primates to evaluate the potential effects on these systems. The current study is part of a multidisciplinary effort to characterize the behavioral, neuroimaging, neuropathological and neurochemical consequences of chronic Mn exposure in non-human primates. This report provides data that indicates a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by guest on November 4, 2016 http://toxsci.oxfordjournals.org/
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Mn-induced deficit in GS levels in the globus pallidus that could potentially alter astrocytic or synaptic levels of glutamate.
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Brains were harvested and embedded in warm 3% low-melting point agarose. After the agarose hardened, the brains were sliced in a series of 0.4 cm coronal slabs using a commercial meat slicer. The left hemisphere was immediately frozen on dry ice, and stored at -80°C until use for metals and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by guest on November 4, 2016 http://toxsci.oxfordjournals.org/ Downloaded from neurotransmitter analysis or quantitative autoradiography of neuroreceptors and transporters. The 0.4 cm slabs from the left hemisphere were sectioned at 20 µm and thaw-mounted onto slides. The slides were then stored at -80 o C until use. The right hemisphere was post-fixed in paraformaldehyde and used for immunohistochemistry. Fifty micron sections were prepared free-floating on a freezing microtome and stored in 50% glycerol at -20°C until use.
HPLC-fluorescence detection of glutamate, glycine, and GABA in brain tissue: Multiple brain areas were assayed for concentrations of glutamate, GABA, and glycine using an HPLC (Shimadzu North America, Columbia, MD, USA) system with fluorescence detection. Each sample was assayed according to a modification of a previously described protocol (Guilarte 1989) . A 50 mM internal standard homoserine stock solution was prepared in 50% methanol. The homogenization solution was prepared by diluting this internal standard solution 1:20 in absolute methanol. Tissue from each brain area was processed independently, and the samples were assayed immediately following processing.
Tissue samples were sonicated with ten one-second pulses in homogenization solution in a volume (in µl) ten times that of the sample mass (in mg). The disrupted tissue was then centrifuged at 27,000 x g at 4 o C for five minutes, and the resulting supernatant was filtered through Phenex 4 mm non-sterile 0.2 µm nylon syringe filters. The samples were then stored at 4 o C until HPLC analysis on the same day. Derivatizing solution was prepared by mixing 65.5 mg Ophthaldialdehyde, 100 µl of β-mercaptoethanol, and 2.5 ml methanol, and the non-specific binding, for 40 minutes at 4 o C. Slides were then rinsed twice for one minute each in ice-cold buffer.
For N-methyl-D-aspartate (NMDA) receptor autoradiography, slides were pre-incubated for 30 minutes at room temperature in 50 mM Tris acetate buffer, pH 7.4 (Jett and Guilarte 1995). Slides were then dried for 30 minutes at 37 o C.
Slides were labeled in buffer containing 50 µM glutamate and 20 µM glycine in the presence of 2.5 nM [ 3 H]-MK-801 (27.5 Ci/mmol, Perkin Elmer), a selective ligand for the NMDA receptor, with or without 100 µM of unlabeled MK-801 in adjacent sections to correct for non-specific binding, for one hour at room temperature. Slides were then rinsed twice for two minutes in ice-cold buffer, followed by a thirty minute rinse in ice-cold buffer.
For glutamate transporter autoradiography, slides were then pre-incubated for 20 minutes in ice cold 50 mM Tris HCl buffer, pH 7.4, containing 300 mM NaCl (Parsons and Rainbow 1983) . Slides were labeled in buffer containing 40 nM [ 3 H]-D-aspartate (23.9 Ci/mmol, Perkin Elmer), a ligand that binds to all glutamate transporter subtypes, with or without 200 µM of unlabeled D-aspartate to correct for non-specific binding, for 20 minutes at 4 o C. Slides were then rinsed twice for five minutes in ice-cold buffer.
In all quantitative receptor autoradiography studies, slides were dipped in cold water and dried under a stream of cool air, then apposed to KODAK BioMax MR film, MR-1, along with [ 3 H]-Microscales (Amersham, Arlington Heights, IL, USA), for 4-8 weeks. Reference standards were included with each film to ensure the linearity of optical density and to allow quantitative analysis of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by guest on November 4, 2016 http://toxsci.oxfordjournals.org/ Downloaded from images. Images were captured and digitized using Inquiry (Loats Assoc.,
Westminster MD) and the optical density was quantified (NIH Image Version 1.63).
Autoradiography was conducted using slides of coronal brain sections that represent the following areas: frontal cortex (Bregma 9.00mm); caudate/putamen and globus pallidus (Bregma -6.75mm); hippocampus (Bregma -11.25mm); and, cerebellum (Bregma -30.60mm). A rhesus monkey brain atlas was used to define distinct brain areas (Paxinos et al. 2000) . Imaging software was use to delineate and measure binding intensity in all areas. Areas 9/46D, 46D, 46V, and 9/46V (see Figure 1A ) reflect regions of the dorsolateral frontal cortex. Area Specific binding in the deep cerebellar nucleus (DCN) and the lobules was measured. Lobular intensity above and below the DCN was averaged to yield a single measure of specific binding in the cerebellar lobules.
Page 12 of 40 Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Immunohistochemistry of glutamine synthetase: Tissue sections were pretreated with 3% H 2 O 2 and 10% methanol in Tris-buffered saline (TBS) for 20 min.
Sections were then incubated with 5% normal horse serum and 0.2% Triton X-100 in TBS for one hour. Further, sections were incubated with a mouse monoclonal antibody reactive to human glutamine synthetase (BD Biosciences, 1:5000, 48 hrs at 4˚C) followed by incubation with the corresponding secondary biotinylated IgG (1:250, Vector, 1.5 hr, at room temperature) and the avidinbiotin-peroxidase complex solution (1:170, 1 hr at room temperature). The reaction product was visualized with 0.25 mg/ml 3,3'-diaminobenzidine and 0.03% H 2 O 2 . Sections were mounted on slides, stained with cresyl violet, dehydrated in graded ethanols and cover-slipped using dibutyl phthalate xylene (DPX) mounting media.
Metals analysis in brain tissue:
Concentrations of Mn were measured in tissue from the frontal cortex, frontal white matter, globus pallidus, caudate and putamen from control and Mn-exposed animals as previously described (Guilarte et al. 2006a) .
Statistics:
Comparison of paired groups of control versus Mn-exposed tissue was conducted using a Student's t-test, with p<0.05 used as a threshold for statistical significance. Alternatively, to correct for multiple comparisons of means, a threshold of p<0.025 was also considered for statistical significance in the Student's t-test. Linear regression analysis with p<0.05 was used to (n=6) and Mn-exposed (n=11) animals. Significant accumulation of Mn occurred in all regions analyzed, with the greatest degree of accumulation present in the globus pallidus (Table 2) .
HPLC Detection of Amino Acid Neurotransmitters: Glutamate, glycine and
GABA concentrations were measured in thirteen brain areas including white and gray matter, regions of the basal ganglia, hippocampus, thalamus and cerebellum. Table 3 shows the average glutamate, GABA, and glycine concentrations for control and Mn-exposed animals. Statistical analysis revealed no significant differences between control and Mn-exposed monkeys in any of the brain regions analyzed.
[ 3 H]-Muscimol Autoradiography: The regional distribution of GABAa receptors was determined by using the specific ligand [ 3 H]-muscimol. A representative image of total [ 3 H]-muscimol binding in each brain region analyzed is shown in Figure 1 . Table 4 shows the average levels of [ 3 H]-muscimol binding in control and Mn-exposed animals. [ 3 H]-muscimol binds prominently throughout the cortex, with a greater degree of binding present in the superficial cortical layers.
Superficial and deep cortical layers were measured separately and as a whole. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 MK-801 in the globus pallidus, thalamus, and cerebellum was too low to measure.
[ 3 H]-D-Aspartate Autoradiography: Regional levels of glutamate transporters were visualized using quantitative autoradiography with the glutamate-transporter Table 4 shows the specific binding of [ 3 H]-D-aspartate in multiple brain areas. No statistically significant differences were observed between control and Mn-exposed animals in the brain regions measured. Negligible uptake of [ 3 H]-D-aspartate was noted in the thalamus and globus pallidus.
Glutamine Synthetase Immunohistochemistry:
Immunohistochemistry was performed to assess the relative levels of GS in the globus pallidus, caudate and putamen in control and Mn-exposed animals. Semi-quantitative densitometry of GS-stained sections revealed comparable levels of expression of GS in the caudate and putamen in control and Mn-exposed animals (Figure 2 ). However, in both the exterior and interior globus pallidus, GS staining was consistently reduced (37%, GPe, p=0.01; 33%, GPi, p=0.03) in the Mn-exposed animals relative to the control animals. These data represent tissue from animals in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 which matching sections of globus pallidus were available (4 control and 6 Mnexposed animals). Nevertheless, the results indicate that chronic Mn exposure affects GS protein levels. When the GS immunohistochemistry was plotted against Mn concentrations in the globus pallidus, there were highly significant negative correlations in both the internal and external globus pallidus. That is, GS levels decreased as the Mn content in the GP increased ( Figure 2 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 by guest on November 4, 2016 http://toxsci.oxfordjournals.org/
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Discussion
In the present study, we examine markers for the glutamatergic and GABAergic systems in the brain of Mn exposed non-human primates. Our findings indicate that these systems, at the levels of Mn exposure used, are minimally affected with the exception of the enzyme GS that is decreased in the globus pallidus of Mn-exposed animals. It is important to note that previous studies in this same group of animals has shown significant reductions of in vivo dopamine release in the striatum measured by PET that were associated with Lastly, behavioral assessments of these animals have shown deficits in cognitive function (Schneider et al. 2006 ) and working memory (Schneider et al. 2009 ), with subtle effects on fine motor control (Schneider et al. 2006 ). The findings within indicate these behavioral effects of chronic Mn exposure are not likely to be attributable to modulation of glutamate, GABA, and glycine neurotransmitter levels.
Several studies conducted in rodents have documented Mn-induced alterations in the brain concentrations of glutamate and GABA. However, little information is available from higher species that addresses this association. (Danbolt 2001) . Due to limited tissue availability, we were unable to analyze these parameters in parallel by Western blot analysis.
Immunohistochemical analysis of GS did show a consistent decrease in the globus pallidus among the available Mn-exposed animals. Glutamine synthetase binds four molecules of Mn per octamer, and up to 80% of brain Mn can normally be associated with GS (Prohaska 1987) . This astrocytic enzyme consumes ATP in the conversion of glutamate and ammonia into glutamine.
Glutamine is transported to presynaptic neurons and used as a precursor for glutamate and GABA synthesis. A direct effect of Mn on GS levels may partially explain the decrease in GS in the globus pallidus but not the caudate or putamen, given that Mn accumulated to the greatest extent in the globus pallidus of these animals. GS is sensitive to oxidative stress and reactive oxygen species can cause structural changes in GS (Butterfield et al. 1997 ). Furthermore, oxygen radicals inactivate GS in vitro and in vivo (Schor 1988 ). Increased astrocytic ammonia, which would result from a decrease in GS levels, has been associated with protein oxidation, proteasomal activity and an increase in astrocytic reactive oxygen species (Widmer et al. 2007 ). Reduced GS activity may therefore reflect an increase in oxidative stress within astrocytes. In addition, an elevation of intracellular ammonia is known to cause astrocytic swelling (Norenberg et al. 2005) . Interestingly, a 24 hour exposure of cultured astrocytes to Mn also causes cellular swelling (Rama Rao et al. 2007 ). This suggests a potential linkage between reduced GS levels observed in our Mn-exposed animals and a Mn-induced pathological astrocytic change. Further studies are Irrespective of the cause of reduced GS levels, the effect of this reduction must be considered. GS is involved in the glutamate-glutamine cycle, which is responsible for the recycling of glutamate at the level of the synapse. Reductions in GS may cause dysregulation of this recycling pathway and by mass action a reduction in the conversion of glutamate into glutamine that could lead to an increase in astrocytic or synaptic glutamate and ammonia concentrations. This could produce altered astrocytic function and disrupt the tight control of glutamate concentration in the synapse. Increased ammonia in astrocytes causes a decrease in glutamate uptake and an increase in glutamate release (Rose 2006 ), which appears to be mediated through the reversal of astrocytic glutamate transporters (Rose 2006 ) and calcium-dependent vesicular release from astrocytes (Rose et al. 2005 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Guilarte, T. R., Burton, N. C., McGlothan, J. L., Verina, T., Zhou, Y., Alexander, M., Pham, L., Griswold, M., Wong, D. F., Syversen, T., and Schneider, J. S. (2008a) . Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J Neurochem. 107, 1236-1247 .
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